Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

about

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

Item

http://www.wikidata.org/entity/Q54215285

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@en

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@nl

type

Item

label

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@en

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@nl

prefLabel

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@en

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.

@nl

P1476

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus

@en

P2093

Vida Dennis

http://www.w3.org/2001/XMLSchema#string

Yvonne Perrie

http://www.w3.org/2001/XMLSchema#string

P2860

Structural characterization of the human respiratory syncytial virus fusion protein core

Inhibition of the Human Respiratory Syncytial Virus Small Hydrophobic Protein and Structural Variations in a Bicelle Environment

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

Challenges and opportunities in developing respiratory syncytial virus therapeutics

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Respiratory syncytial virus infection in elderly and high-risk adults.

Liposomes as vaccine delivery systems: a review of the recent advances.

P31

scholarly article

P356

10.3390/BIOENGINEERING5020037

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29747393

http://www.w3.org/2001/XMLSchema#string

P932

6027156

http://www.w3.org/2001/XMLSchema#string